Related references
Note: Only part of the references are listed.Bacterial infections in patients hospitalized with COVID-19
Victor Moreno-Torres et al.
INTERNAL AND EMERGENCY MEDICINE (2022)
The cytokine storm and COVID-19
Biying Hu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)
Chaolin Huang et al.
LANCET (2021)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Lymphopenia in COVID-19: Therapeutic opportunities
Nazanin Fathi et al.
CELL BIOLOGY INTERNATIONAL (2020)
COVID-19 and the clinical hematology laboratory
John L. Frater et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
Chiara Minotti et al.
JOURNAL OF INFECTION (2020)
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
Ya Gao et al.
JOURNAL OF INFECTION (2020)
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Andrew I. Ritchie et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
COVID-19, ECMO, and lymphopenia: a word of caution
Brandon Michael Henry
LANCET RESPIRATORY MEDICINE (2020)
Focus on the 2019 novel coronavirus (SARS-CoV-2)
Ling-Pu Zhang et al.
FUTURE MICROBIOLOGY (2020)
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
Phil-Robin Tepasse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression
Robin Jeannet et al.
INTENSIVE CARE MEDICINE (2020)
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
Qianwen Zhao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
Marie Helleberg et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma
Hajime Yasuda et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
SARS-CoV2 and immunosuppression: A double-edged sword
Quirino Lai et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Natural history of COVID-19 and therapeutic options
Philippe Gautret et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients
Michael Zapor
VIRUSES-BASEL (2020)
The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients
Ali Haider Mohammed et al.
AIDS REVIEWS (2020)
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Vassilis G. Giannakoulis et al.
JCO GLOBAL ONCOLOGY (2020)
COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu et al.
CANCER BIOLOGY & MEDICINE (2020)
COVID-19: immunopathogenesis and Immunotherapeutics
Li Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Li Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
Stuart A. Grossman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
SEVERE LYMPHOPENIA IS ASSOCIATED WITH ELEVATED PLASMA INTERLEUKIN-15 LEVELS AND INCREASED MORTALITY DURING SEVERE SEPSIS
Kuei-Pin Chung et al.
SHOCK (2015)
SpO2/FiO2 Ratio on Hospital Admission Is an Indicator of Early Acute Respiratory Distress Syndrome Development Among Patients at Risk
Emir Festic et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2015)
Acute Respiratory Distress Syndrome The Berlin Definition
V. Marco Ranieri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Share Paper
